Cam Watson delivers a startling premise: the next great leap in biotechnology won't happen in a digital simulation, but in a physical, automated lab—and China is already building the infrastructure to win it. While Western discourse often fixates on software models, Watson argues that the true bottleneck in biology is the inability to rapidly test hypotheses in the real world, a gap China is filling with state-backed "embodied AI" systems that fuse robotics with artificial intelligence.
From Digital Dreams to Physical Reality
Watson begins by dismantling the assumption that AI in science is purely about prediction. He notes that while early breakthroughs like DeepMind's AlphaFold solved the protein folding problem, they hit a wall: "These systems could make astonishing predictions but they could not test them." The author argues that biology is too messy for pure simulation; it requires a closed loop where an AI generates a hypothesis, a robot executes the experiment, and the resulting data immediately refines the algorithm.
The core of Watson's argument is that this "embodied" approach transforms biology from a slow, artisanal craft into a scalable engineering discipline. He writes, "Biology is not a problem you can solve entirely on a screen." This distinction is crucial. In fields like finance or logistics, AI operates in a digital realm, but biological engineering involves "dozens of variables, from temperature and pH to nutrient concentrations and gene expression levels, all of which interact in unpredictable ways." Watson suggests that only by embedding intelligence directly into physical infrastructure can we manage this complexity.
Critics might argue that the West still holds a significant lead in foundational AI research and that hardware lags are temporary. However, Watson counters that the integration of hardware and software is the new moat, and the West's fragmented approach to building this infrastructure puts it at a disadvantage.
"Embodied AI rewires the flow of experimentation. It turns biology from a slow, artisanal craft into a scalable, data-driven engineering discipline."
The China Advantage: Infrastructure as Strategy
Watson shifts to the geopolitical landscape, observing that China has treated biotech and AI as national priorities rather than market-driven ventures. He points to the "state-led investment and direction" that allows for the rapid construction of biofoundries and automated wet labs. Unlike the West, where funding relies on volatile venture capital cycles, the Chinese government has provided the capital to build the "ideal substrate for embedding agentic AI systems."
A prime example Watson highlights is BioMARS, a language-driven robotic scientist that coordinates specialized AI roles to autonomously run wet-lab protocols. He explains that unlike earlier digital twin approaches, "BioMARS directly links natural language instructions to physical experiments." This system represents a shift toward multi-agent frameworks where tasks are distributed across specialized roles, mirroring a human research team but operating at machine speed.
The author also emphasizes the importance of ecosystem integration. Cities like Suzhou and Shanghai are building campuses where AI companies, robotics providers, and manufacturing facilities sit side by side. Watson notes that "this co-location drastically reduces friction between discovery, validation and scaling." He cites BioBAY in Suzhou, which has already brought 15 therapeutics to market and spawned 54 unicorns, as evidence that this model works.
"The same engineering mindset that enabled precision electronics assembly is mass producing cost effective robotic platforms sensitive enough to pipette microliters of liquid, handle fragile cell cultures and run assays around the clock."
Watson also identifies a less discussed but critical factor: the stability of China's national electricity grid. He argues that robotics-heavy labs are extremely sensitive to power fluctuations. "A reliable, unified grid allows large-scale labs to run automated experiments continuously, without the costly interruptions or redundancies that plague more fragmented energy systems in other countries." This infrastructure advantage, combined with a talent pipeline that now mandates AI education from age six, creates a fertile ground for rapid iteration.
The Global Stakes
The piece concludes with a sobering assessment of the global implications. Watson frames this not just as a competition, but as a structural shift comparable to the internet revolution. He warns that "there will be a ChatGPT moment for biotechnology, and if China gets there first, no matter how fast we run, we will never catch up." This quote, attributed to a US National Security Commission warning, underscores the urgency of the situation.
Watson suggests that the West faces a strategic choice: treat China solely as a competitor to race against, or find ways to collaborate on standards and supply chains. He posits that "China's scale ensures it will set part of the global agenda," regardless of Western policy. The argument is that embodied AI will not develop in isolation; the geography of where this infrastructure is built will dictate the future of drug discovery and biomanufacturing.
Critics might note that Watson's reliance on government-led models overlooks the potential for Western private-sector agility and the risks of state-directed scientific priorities. Yet, the sheer scale of the infrastructure being deployed in China suggests that the "race" is already well underway, and the rules of engagement are being written in Shanghai and Suzhou.
"The real question to me isn't whether China takes the lead or not but how the rest of the world is choosing to engage with China."
Bottom Line
Watson's strongest contribution is reframing the AI race from a software contest to a battle over physical infrastructure and industrial integration. His argument is compelling because it moves beyond the hype of large language models to the gritty reality of wet-lab automation. The biggest vulnerability in his analysis is the assumption that state-led efficiency will always outperform market-driven innovation, a tension that remains unresolved. However, the evidence of China's rapid scaling in this specific niche suggests that the West must urgently reconsider how it builds its own scientific infrastructure to avoid falling behind in the next industrial revolution.